Full Name
Chung, T.-H.
Variants
Chung, T.-H.
Chung, T.H.
 
 
Email
csicth@nus.edu.sg
 

Publications

Results 1-15 of 15 (Search time: 0.018 seconds).

Issue DateTitleAuthor(s)
120-Jun-2013A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple MyelomaChung, T.-H. ; Mulligan, G.; Fonseca, R.; Chng, W.J.
220-Sep-2018Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisTeoh, Phaik Ju ; An, Omer ; Chung, Tae-Hoon ; Chooi, Jing Yuan ; Toh, Sabrina HM ; Fan, Shuangyi ; Wang, Wilson ; Koh, Bryan TH; Fullwood, Melissa J ; Ooi, Melissa G ; de Mel, Sanjay; Soekojo, Cinnie Y; Chen, Leilei ; Ng, Siok Bian ; Yang, Henry ; Chng, Wee Joo 
3Jun-2011Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myelomaChng, W.-J.; Huang, G.F. ; Chung, T.H. ; Ng, S.B.; Gonzalez-Paz, N.; Troska-Price, T.; Mulligan, G.; Chesi, M.; Bergsagel, P.L.; Fonseca, R.
42013Clonogenic multiple myeloma cells have shared stemness signature associated with patient survivalReghunathan, R. ; Bi, C.; Liu, S.C.; Loong, K.T.; Chung, T.-H. ; Huang, G. ; Chng, W.J.
52010Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: Identification of 1p31-32 deletion as a prognostic factor in myelomaChng, W.J. ; Van, Wier S.; Keats, J.J.; Bergsagel, P.L.; Fonseca, R.; Gertz, M.A.; Chung, T.-H. ; Baker, A.; Carpten, J.
6Oct-2013Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaYan, J. ; Jiang, N.; Huang, G. ; Tay, J.L.-S.; Lin, B.; Bi, C.; Koh, G.S.; Li, Z.; Tan, J.; Chung, T.-H. ; Lu, Y.; Ariffin, H.; Kham, S.K.Y.; Yeoh, A.E.J.; Chng, W.-J.
722-May-2020Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaZhang, X.Y.; Rajagopalan, D. ; Chung, T.-H. ; Hooi, L. ; Toh, T.B. ; Tian, J.S. ; Rashid, M.B.M.A.; Sahib, N.R.B.M. ; Gu, M.; Lim, J.J. ; Wang, W. ; Chng, W.J. ; Jha, S. ; Chow, E.K.-H. 
82015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
92008High-resolution analysis of condition-specific regulatory modules in Saccharomyces cerevisiaeLee, H.-G; Lee, H.-S; Jeon, S.-H; Chung, T.-H ; Lim, Y.-S; Huh, W.-K
1015-Sep-2019IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple MyelomaChong, Phyllis SY ; Zhou, Jianbiao ; Lim, Julia SL ; Hee, Yan Ting; Chooi, Jing-Yuan ; Chung, Tae-Hoon ; Tan, Zea Tuan ; Zeng, Qi ; Waller, Daniel D; Sebag, Michael; Chng, Wee-Joo 
111-Aug-2013Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cellsAl-Aidaroos, A.Q.O.; Yuen, H.F.; Guo, K.; Zhang, S.D.; Chung, T.-H. ; Chng, W.J.; Zeng, Q. 
122020Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: A potential targeted agent in the treatment of PMBLChu, Y.; Awasthi, A.; Lee, S.; Edani, D.; Yin, C.; Hochberg, J.; Shah, T.; Chung, T.-H. ; Ayello, J.; van de Ven, C.; Klein, C.; Lee, D.; Cairo, M.S.
132017The effects of DLEU1 gene expression in Burkitt lymphoma (BL): Potential mechanism of chemoimmunotherapy resistance in BLLee, S; Luo, W; Shah, T; Yin, C; O'Connell, T; Chung, T.-H ; Perkins, S.L; Miles, R.R; Ayello, J; Morris, E; Harrison, L; van de Ven, C; Cairo, M.S
142018The genomics and molecular biology of natural killer/T-cell lymphoma: Opportunities for translationde Mel S.; Soon G.S.-T.; Mok Y.; Chung T.-H. ; Jeyasekharan A.D. ; Chng W.-J. ; Ng S.-B. 
152017VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of BimMustafa, N ; Ting Lee, J.X ; Adina Nee, H.F ; Bi, C; Chung, T.-H ; Hart, S; Chng, W.J